become a promising treatment for NF1. © 2022, Tomsk National Research
Medical Center of the Russian
Asadi-Pooya, AA,
Trinka, E,
Brigo, F,
Hingray, C,
Karakis, I,
Lattanzi, S,
Valente, KD,
Contreras, G,
Turuspekova, ST,
Kishk, NA,
Aljandeel, G,
Farazdaghi, M,
Lopez, YC,
Kissani, N,
Triki, C,
Kramer, G,
Surges, R,
Mesraoua, B,
Yu, HY,
Daza-Restrepo, A,
Alsaadi, T,
Al-Asmi, A,
Kutlubaev, MA,
Pretorius, C,
Jusupova, A,
Khachatryan, SG,
Ranganathan, LN,
Ashkanani, A,
Tomson, T,
Gigineishvili, D (2022) this condition were considered to be those with poor anti-seizure
medication (ASM) adherence, frequent tonic
Medical Association. All rights reserved.